Linked Life Data

9337547

Source:http://linkedlifedata.com/resource/pubmed/id/9337547

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1997-12-8
pubmed:abstractText
The existence of large interindividual differences in oxidation phenotypes and link of them with susceptibility to certain cancers was shown in animal and human studies. In a new approach plasma antipyrine half-lives have been measured in 60 lung cancer patients, 56 their first degree relatives and 75 healthy controls without cancer in their families. The mean antipyrine half-lives were significantly shorter (p < 0.005) in lung cancer patients group and in the group of their relatives when compared with the cancer free matched control group. This difference remained significant after adjusting for smoking gender and age. Six adenocarcinoma patients have shown significantly faster antipyrine metabolism than subjects with other histological types of lung cancer and obviously than healthy control.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:author
pubmed:volume
42 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
297-308
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Antipyrine metabolism in lung cancer patients and their relatives.
pubmed:affiliation
III Department of Tuberculosis and Chest Diseases, National Institute of Tuberculosis and Lung Diseases, Warsaw.
pubmed:publicationType
Journal Article, Comparative Study